Melanie Werner-Klein has studied biology in Germany and Canada and obtained her PhD in Immunology at the LMU Munich in 2005 on B-cell mediated tolerance induction in CD8 T-cells. During her post-doctoral period at Boehringer-Ingelheim Pharma in the department of respiratory research, she worked on small animal models for asthma and the modulation of the asthmatic response by Toll-like receptor ligands. Since 2007 she is at the University of Regensburg, Institute of Immunology and, supported by the DFG and the University of Regensburg, started her own group on tumour immunology. Melanie Werner-Klein is married and has two children.
Abstracts this author is presenting: